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INCREASED ERROR-RELATED BRAIN ACTIVITY IN
YOUTHWITH OBSESSIVE-COMPULSIVE DISORDER
AND UNAFFECTED SIBLINGS
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Background: The pathophysiology of obsessive-compulsive disorder (OCD) in-
volves increased activity in cortico-striatal circuits connecting the anterior cingu-
late cortex (ACC) with other brain regions. The error-related negativity (ERN)
is a negative deflection in the event-related potential following an erroneous
response and is thought to reflect ACC activity. This study was done to assess
the ERN as a biomarker for OCD by comparing ERN amplitudes in pediatric
OCD patients, unaffected siblings of pediatric OCD patients, and healthy con-
trols.Methods: The ERN and correct response negativity (CRN) were measured
during an Eriksen flanker task to assess performance monitoring in 40 youth
with a lifetime diagnosis of OCD, 19 unaffected siblings of OCD patients, and
40 unrelated healthy comparison subjects ranging in age from 10 to 17 years.
ERN and CRN amplitudes were compared between groups using linear regres-
sion by the generalized estimating equation method to account for correlated
data. Results: Compared to healthy controls, ERN amplitude was significantly
increased in both pediatric OCD patients and unaffected siblings. There were
no significant group differences in CRN amplitude. ERN amplitude in patients
was unrelated to OCD symptom severity, current diagnostic status, or treatment
effects. Conclusions: Increased error-related brain potentials were observed not
only in pediatric OCD patients but also in unaffected siblings. The results provide
evidence that enhanced error-related brain activity may serve as a biomarker for
OCD in youth that is independent of the presence of clinical symptoms. The ERN
may be a useful quantitative phenotype in genetic studies of OCD. Depression
and Anxiety 30:39–46, 2013. C© 2012 Wiley Periodicals, Inc.
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INTRODUCTION
Obsessive-compulsive disorder (OCD) [http://www.
omim.org/entry/164230] is a heterogeneous psychiatric
disorder with lifetime prevalence estimates ranging from
1 to 3% and a median age at onset of 19 years.[1]
Twin and family studies provide evidence that OCD is a
complex trait with both genetic and environmental sus-
ceptibility factors.[2–11] Estimates of the heritability of
obsessive-compulsive (OC) symptoms range from 27 to
47% in adults and from 45 to 65 in children.[2–5] Family
studies indicate that the lifetime prevalence of OCD is
Published online 5 December 2012 in Wiley Online Library (wiley-
onlinelibrary.com).
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substantially higher in case compared to control first-
degree relatives, and that OCD risk is at least doubled
in case relatives of pediatric probands compared to case
relatives of adult probands.[6–11] Genetic linkage analy-
ses have provided suggestive evidence for susceptibility
loci on chromosomes 9p24[12,13] and 15q14;[14,15] how-
ever, linkage findings for those and other chromosomal
regions have not been consistently replicated.[12–17] Fur-
ther efforts to identify susceptibility loci for OCD may
benefit from use of a quantitative phenotype, which ei-
ther mediates between genes and the clinical phenotype
on the causal pathway or indicates risk by sharing sets of
genes with the clinical phenotype.[18,19]
Functional brain imaging studies suggest the patho-
physiology of OCD involves increased activity in
cortico-striatal circuits connecting the anterior cingulate
cortex (ACC) with other brain regions.[20,21] Functional
magnetic resonance imaging (fMRI) studies of OCD pa-
tients have found increased error-related brain activity
localized to the ACC.[22,23] The observation of increased
error-related brain activity in OCD patients is consis-
tent with the hypothesis that OCD involves defects in an
error-detection system, which may give rise to repeated
doubts about actions and excessive worries about poten-
tial mistakes.[24] It remains unclear, however, whether
increased error-related brain activity may contribute to
the expression or suppression of OCD symptoms. Con-
sistent with the latter possibility, improvement in OCD
symptoms during intensive cognitive-behavioral therapy
was associated in an imaging study with increased dorsal
ACC metabolic activity.[21]
The error-related negativity (ERN)[25,26] or error
negativity [27] is a frontally maximal negative deflec-
tion in the response-locked event-related potential
that peaks within 100 ms after an incorrect re-
sponse, which can be evoked by errors commit-
ted outside of conscious awareness.[28] Studies us-
ing fMRI,[29] magnetoencephalography,[30] and dipole
source localization[31] have suggested the ERN is gen-
erated mainly by the dorsal ACC. ERN amplitude
generally increases with age, which may reflect ACC
maturation.[32] The ERN has been hypothesized to
reflect error detection, response conflict, or reward
prediction errors in which outcomes are worse than
expected.[26] A study of 12-year-old twins found that
genetic factors account for 47% of the variance in the
ERN, suggesting it may serve as an endophenotype in
genetic studies of psychopathology.[33]
In studies using tasks eliciting response conflict,
ERN amplitude has been increased in adult patients
with OCD[34–41] and young adults with self-reported
OC symptoms.[42] Several of those studies also found
that serotonergic antidepressants had no effect on the
ERN in OCD patients.[38–40] Furthermore, ERN am-
plitude has been increased in studies of pediatric pa-
tients with OCD[43] and children with parent-reported
OC symptoms.[44] In the study of pediatric OCD pa-
tients, the ERN did not change as a function of the re-
duction in OCD symptoms with cognitive-behavioral
therapy, indicating that increased ACC activity dur-
ing response monitoring does not necessarily maintain
OCD symptoms and that an increase in this brain po-
tential may serve as a trait marker or endophenotype
forOCD.[43,45] Similarly, increased ERN amplitude was
found in the unaffected first-degree relatives of adult
OCD probands, providing further evidence that over-
active error monitoring may serve as a biomarker for
OCD that is independent of the presence of clinical
symptoms.[39]
Since the ERN has been examined to a limited ex-
tent in pediatric OCD patients[43] and unaffected adult
first-degree relatives ofOCDprobands,[39] the following
study was conducted with 40 youth with a lifetime diag-
nosis of OCD, 19 unaffected siblings of pediatric OCD
probands, and 40 age-matched healthy controls using
a flanker task that elicits response conflict. The aim of
the study was to demonstrate that ERN amplitude is in-
creased in both pediatric OCD patients and unaffected
siblings compared to healthy controls.
METHOD
PARTICIPANTS
Pediatric OCD patients and unaffected siblings of pediatric OCD
probands were recruited from the Department of Psychiatry at the
University of Michigan and surrounding community. Pediatric com-
parison subjects were recruited from the surrounding community. The
control parents reported no history ofOCDor tic disorders in the first-
degree relatives of their children. After complete description of the
study, written informed consent was obtained from at least one parent
of the participant and written informed assent from the participant.
Participants were paid for their interviews and psychophysiological
recordings. Participants were matched for age and gender.
All 40 patients had a lifetime diagnosis of OCD. Patients were ex-
cluded if they had a lifetime diagnosis of autistic disorder, Asperger’s
disorder, schizophrenia, other psychotic disorder, bipolar I disorder,
substance-related disorder, or anorexia nervosa, or a current diagnosis
of major depressive disorder. All 19 unaffected siblings and 40 com-
parison subjects had no history of a specific axis I disorder. Eleven un-
affected siblings were related to participants in the patient group. The
other eight unaffected siblings were recruited through pediatric OCD
probands who were evaluated using the same diagnostic instruments
as the participants in this study. Lifetime and current axis I diagnoses
were made independently by two clinicians using all sources of in-
formation according to DSM-IV-TR criteria.[46] Patients, unaffected
siblings, and comparison subjects were excluded if they had a history of
mental retardation, head injury with a sustained loss of consciousness,
chronic neurological disorder such as a seizure disorder, or a score≥15
on the lifetime version of the Social Communication Questionnaire,
to further minimize the possibility of participants having a history of
autism spectrum disorder.[47] All participants lived with at least one
English-speaking biological parent who was willing to participate in
research.
All 99 participants were interviewed with the Schedule for
Schizophrenia and Affective Disorders for School-Aged Children-
Present and Lifetime Version[48] and Schedule for Obsessive-
Compulsive and Other Behavioral Syndromes.[49] The lifetime and
current severity of OCD was assessed in patients with a modified
version of the Children’s Yale–Brown Obsessive Compulsive Dis-
order Scale (CY-BOCS),[50] with patients and their parents provid-
ing item scores retrospectively for the most severe episode of OCD
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along with item scores for current severity. The parent report scales
completed for all participants consisted of the Child Behavior Check-
list (CBCL)[51,52] and Social Communication Questionnaire.[47] The
self-report scales completed by all participants consisted of the Mul-
tidimensional Anxiety Scale for Children (MASC)[53] and Children’s
Depression Inventory (CDI).[54]
Table 1 summarizes the demographic, clinical, behavioral, and
event-related brain potential data for the OCD patients, unaffected
siblings of OCD probands, and healthy controls. Participants ranged
in age from 10 to 17 years. The OCD group had 18 males, the un-
affected sibling group 13 males, and the comparison group 20 males
(χ2 = 2.89, df = 2, P = .24). The current and lifetime CY-BOCS
scores in the OCD patients ranged from 0 to 34 and 12 to 36, respec-
tively. Although all patients had a lifetime diagnosis of OCD, 25 had a
current diagnosis and 15 a past diagnosis with minimal current OCD
symptoms that no longer met criteria for diagnosis. Of the 40 OCD
patients, 24 had a history of at least one other axis I diagnosis. The
disorders (and number of patients with the diagnosis) were the follow-
ing: tic disorder (N = 8), trichotillomania (N = 2), attention-deficit
hyperactivity disorder (N = 2), separation anxiety disorder (N = 6),
panic disorder (N = 1), specific phobia (N = 6), social phobia (N = 7),
agoraphobia (N = 1), generalized anxiety disorder (N = 7), and past
major depressive disorder (N = 4). Consistent with previous studies
of the ERN in OCD, patients were included in the study if they were
taking a stable dose of a selective serotonin reuptake inhibitor (SSRI)
but no other psychotropic medications. Medications being taken (and
number of patients taking the medication) were the following: fluoxe-
tine (N = 11), sertraline (N = 2), escitalopram (N = 2), and citalopram
(N = 1). No patient was taking more than one SSRI. Prior studies have
found no effect of serotonergic antidepressants on the ERN.[38–40]
TASK AND PROCEDURE
Participants performed a modified Eriksen flanker task in which
arrows appeared on a computer display with congruent (e.g.
→→→→→) and incongruent (e.g. →→←→→) conditions.[55]
They were instructed to respond by pressing one of two buttons indi-
cating the direction of the central arrow (i.e. right versus left), while
ignoring the adjacent arrows, and to respond as quickly and accurately
as possible, while placing equal emphasis on speed and accuracy. The
stimuli remained on the screen for 250 ms, with an interval 1,500 ms
between consecutive stimuli.
Each participant was seated 0.65m directly in front of the computer
monitor. Following a practice block of 32 trials, each subject completed
8 blocks of 64 trials for 512 trials. Performance feedback was provided
after every block to yield error rates of approximately 10%, ensuring
an adequate number of trials for stable error-related waveforms.
ELECTROPHYSIOLOGICAL RECORDING, DATA
REDUCTION, AND ANALYSIS
The EEG was recorded from DC-104 Hz with 64 Ag/AgCl
scalp electrodes, two mastoid electrodes, and two vertical and
two horizontal electro-oculogram electrodes, using the BioSemi
ActiveTwo system (Amsterdam, the Netherlands). Data were
recorded referenced to a ground formed from a common mode
sense active electrode and driven right leg passive electrode (see
http://www.biosemi.com/faq/cms&drl.htm) and were re-referenced
offline to the average of the twomastoid electrodes.Datawere digitized
at 512 Hz. Following recording, the data were resampled at 256 Hz.
Prior to eye movement correction, EEG data were screened using au-
tomated algorithms that rejected individual sweeps in which (a) the
absolute voltage range for any individual electrode exceeded 500 μV,
(b) a change greater than 50 μV was measured from one datapoint to
thenext, or (c) thedata deviatedbymore than+25or –100dB in the 20–
40 Hz frequency window (for detecting muscle artifacts). The ampli-
tude range used for rejection was fairly large so that trials with cor-
rectable eye movements were not eliminated. Data were also screened
by visual inspection. Ocular movement artifacts were then corrected
using the algorithm described by Gratton, Coles, and Donchin.[56]
Waveforms shown in figures were filtered with a nine-point Cheby-
shev II low-pass, zero-phase-shift digital filter (Matlab R2010a; Math-
works, Natick, MA), with a half-amplitude cutoff at approximately
12 Hz.
Behavioral measures included the number of erroneous and correct
trials for each subject, as well as accuracy expressed as a percentage
of valid trials. Average reaction times on error and correct trials were
calculated separately, after excluding trials with reaction times greater
than 1,500 ms. Reaction time and accuracy after errors were evalu-
ated to determine if there were group differences in post-error behav-
ioral adjustments.[57] Reaction times were analyzed with group as a
between-subject factor and response type as a within-subject factor.
The mean number of errors per subject contributing to the analysis
was 57.4 (SD = 23.4; range = 16–121).
The ERN was quantified using mean amplitude measures relative
to a preresponse baseline –200 to –50 ms. The mean amplitude of the
ERN was computed on incorrect response trials in a window from
0 to 80 ms following the incorrect response. The correct response
negativity (CRN) consisted of the same measure computed on correct
response trials. Amplitudes were calculated for electrodes FCz and Cz.
However, recent studies with children suggest their ERN is slightly
more posterior but temporally similar to the adult ERN,[58] so the
focus of the data presented herein is the ERN at Cz.
ERN amplitude was compared between groups using linear regres-
sion by the generalized estimating equation (GEE) method to account
for correlated data, including error number as a covariate, with the
GENMODprocedure in SASVersion 9.2 software (SAS Institute Inc.,
Cary, NC).[59] Other variables were compared between groups using
linear regression by the GEE method without including error num-
ber as a covariate. ERN amplitude was compared between subgroups
of pediatric OCD patients using analysis of variance. In the compar-
ison of patients with a past or current diagnosis of OCD, tic history
was included as a variable because the ERN and the course and treat-
ment response of OCD may be influenced by comorbid tics.[60,61]
Pearson correlation coefficients or Spearman rank-order correlation
coefficients were used to examine associations of response-related am-
plitudes with age, behavioral measures, and clinical measures. All sta-
tistical tests were two-tailed with the alpha level set at 0.05.
RESULTS
BEHAVIORAL DATA IN OCD PATIENTS,
UNAFFECTED SIBLINGS, AND HEALTHY
CONTROLS
There were no significant group differences in the
number of error trials, reaction time during correct
or error trials, or posterror slowing (Table 1). Correct
responses were significantly slower than incorrect re-
sponses (paired t = 9.91, df = 98, P < .0001). No main
effect of group on response type for reaction time and no
interaction between group and response type for reac-
tion time reached significance (P = .52 and P = .68,
respectively). In all subjects, age had significant neg-
ative correlations with reaction time on correct trials
(r = –.39, P < .0001), reaction time on error trials (r =
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TABLE 1. Demographic, clinical, behavioral, and brain potential data in OCD Patients, unaffected siblings of OCD
Patients, and healthy comparison subjects
Comparisons of OCD
patients, unaffected
Healthy control siblings, and healthy
OCD patients Unaffected siblings control subjects control subjects
(n = 40) (n = 19) (n = 40) Test
Variable Mean SD Mean SD Mean SD statistica P
Demographic and clinical data
Age (years) 13.9 2.4 13.9 2.4 13.8 2.3 χ22 = 0.04 .98
Child Behavior Checklist
Total score 35.1 22.5 7.4 4.7 7.5 5.3 χ22 = 33.27 <.0001b
Internalizing score 14.2 9.1 2.5 2.4 2.5 2.1 χ22 = 35.04 <.0001b
Externalizing score 6.4 6.9 2.2 2.6 1.9 2.0 χ22 = 13.18 <.0014c,d
Obsessive-Compulsive
Scale score
6.6 3.9 0.9 1.4 0.6 0.8 χ22 = 42.14 <.0001b
Multidimensional Anxiety
Scale For Children
(total score)
47.4 20.8 28.6 12.0 27.6 13.1 χ22 = 20.09 <.0001b
Children’s Depression
Inventory
9.8 7.3 3.4 3.8 2.8 2.7 χ22 = 23.33 <.0001b
Age at onset of
Obsessive-Compulsive
Symptoms (years)
8.1 3.2
Duration of
Obsessive-Compulsive
Symptoms (years)
5.6 3.6
Children’s Yale–Brown
Obsessive Compulsive
Scale—lifetime score
28.2 6.1
Children’s Yale–Brown
Obsessive Compulsive
Scale—current score
16.0 8.9
Behavioral data
Total number of error trials 61.6 24.0 56.6 20.8 53.5 23.8 χ22 = 2.48 .29
Total number of correct
trials
432.0 48.7 438.7 30.6 449.1 46.8 χ22 = 2.00 .37
Correct reaction time (ms) 455.5 94.5 464.5 131.0 479.4 115.8 χ22 = 1.04 .60
Error reaction time (ms) 393.7 100.6 405.5 128.4 428.7 146.8 χ22 = 1.56 .46
Post-error reaction time
(ms)
470.7 145.8 453.0 250.5 511.4 234.7 χ22 = 1.10 .58
Event-related brain potential data
Error-related negativity,
FCz (μV)
–4.04 5.36 –4.71 3.92 –2.31 3.65 χ22 = 5.74 .057 e,f
Error-related negativity, Cz
(μV)
–1.46 5.75 –1.39 5.20 1.51 4.90 χ22 = 8.32 .016 g,h
Correct response negativity,
FCz (μV)
2.10 5.52 1.44 4.61 1.94 4.04 χ22 = 0.28 .87
Correct response negativity,
Cz (μV)
3.36 5.92 2.31 4.92 3.68 4.88 χ22 = 1.05 .59
OCD, obsessive-compulsive disorder.
aDetermined using linear regression by the generalized estimating equation method. Degrees of freedom are presented as subscript figures.
bOCD patients significantly different from unaffected siblings, and OCD patients significantly different from healthy controls, P < .0001.
cOCD patients significantly different from unaffected siblings, P = .0009.
dOCD patients significantly different from healthy controls, P < .0001.
eTrend for a difference between OCD patients and healthy controls, P = .052.
fUnaffected siblings significantly different from healthy controls, P = .039.
gOCD patients significantly different from healthy controls, P = .006.
hUnaffected siblings significantly different from healthy controls, P = .037.
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–.24, P = .014), and posterror slowing (r = –.23, P =
.020). However, there was no significant correlation be-
tween age and error number (P = .40). There were no
significant sex differences for error number, reaction
time on correct trials, reaction time on error trials, or
posterror slowing (all P values > .10).
EVENT-RELATED POTENTIAL DATA IN OCD
PATIENTS, UNAFFECTED SIBLINGS, AND
HEALTHY CONTROLS
ERN amplitude at Cz was correlated with age in all
subjects, becoming larger (or more negative) with in-
creasing age (r = –.25, P = .011). ERN amplitude at Cz
had no significant correlations with error number, reac-
tion time on correct trials, reaction time on error trials,
or posterror slowing (all P values > .30).
In a comparison of ERN amplitudes at Cz in OCD
patients, unaffected siblings, and healthy controls, there
was a significant group effect (χ2 = 8.32, df = 2, P =
.016) without a significant error number effect (χ2 =
1.15, df = 1, P = .28; Table 1 and Fig. 1). Compared
to controls, ERN amplitude at Cz was significantly in-
creased in both patients (P = .006, Cohen’s d = .56)
and unaffected siblings (P = .037, Cohen’s d = .57). In
an analysis using both error number and CDI scores as
covariates, the group effect remained significant (χ2 =
8.11, df = 2, P = .017) without a significant effect for
error number (χ2 = 1.15, df = 1, P = .28) or depression
severity (χ2 = 0.00, df = 1, P = .97). In an analysis using
only the 11 sibling pairs and healthy controls, there was
a significant group effect (χ2 = 6.77, df = 2, P = .034)
without a significant error number effect (χ2 = .01, df =
1, P = .90). Compared to controls, ERN amplitude at
Cz was significantly increased in the 11 OCD patients
(P = .002, Cohen’s d = .97), but not in the 11 unaffected
siblings (P = .33, Cohen’s d = .35). There was no sig-
nificant difference in ERN amplitude at Cz between the
11 unaffected siblings with an affected sibling and the
eight unaffected siblings without an affected sibling in
the study (F = 1.03, df = 2,16, P = .38).
There were no significant differences between the
three groups in CRN amplitudes at Cz (P value > .50;
Table 1). There were no significant sex differences in
any brain potentials (all P values > .10).
CLINICAL CORRELATIONS AND COMPARISONS
IN OCD PATIENTS, UNAFFECTED SIBLINGS,
AND HEALTHY CONTROLS
As expected, the groups differed significantly in symp-
tom severity scores from the CBCL, MASC, and
CDI, with OCD patients having significantly higher
scores than unaffected siblings and healthy controls
(Table 1). Moreover, there were no significant dif-
ferences between the unaffected siblings and healthy
controls on any of these measures. In the healthy con-
trols, there was a significant negative correlation be-
tween the CBCL obsessive-compulsive scale (CBCL-
OCS) scores[52] and ERN amplitude at Cz (Spearman
ρ = –.35, P = .025). There were no significant corre-
lations between the CBCL-OCS scores and any brain
potentials in either the OCD patients (all P values >
.30) or unaffected siblings (all P values > .40).
In the pediatric OCD patients, there were no signifi-
cant correlations between any brain potentials and either
current or lifetime measures of OCD symptom severity
(all P values> .20). There were no significant differences
in any brain potentials between patients with a current
or past diagnosis of OCD (all P values > .20). Further-
more, in a comparison of ERN amplitudes at Cz in pa-
tients with a past diagnosis ofOCDand healthy controls,
there was a significant group effect (P = .0013) without
a significant error number effect (P = .24). Similarly, in
a comparison of ERN amplitudes at Cz in patients with
a current diagnosis of OCD and healthy controls, there
was a significant group effect (P = .018) without a signif-
icant error number effect (P = .14). There were no sig-
nificant differences in any behavioral measures or brain
potentials between OCD patients receiving and not re-
ceiving a serotonin reuptake inhibitor (all P values >
.10), or between patients receiving and not receiving
cognitive-behavioral therapy with exposure/response
prevention (all P values > .30).
DISCUSSION
Our finding of an increased ERN in pediatric OCD
patients during a task-eliciting response conflict is con-
sistent with previous reports of increased error-related
brain activity in adults[20–23,34–41] and children[43] with
OCD.ERNresults have beenmore variable, however, in
studies of adult OCD patients using probabilistic learn-
ing tasks or other tasks, indicating the increase is spe-
cific to particular conditions.[62–65] Our results also pro-
vide further evidence that an enlarged ERN in OCD
patients is a more trait-like measure that appears inde-
pendent of OCD symptom severity, current diagnostic
status, or treatment effects.[37–39,43] Nonetheless, it is im-
portant to note this finding is not specific to OCD, as
an enhanced ERN has also been found in generalized
anxiety disorder.[41,45,66,67] The negative correlation be-
tween the ERN and CBCL-OCS scores observed in our
healthy controls is similar to the correlation found in a
previous study of OC behaviors in a nonclinical sample
of children.[44] The ERN may have a stronger correla-
tion with OC behavior severity in individuals without a
clinical diagnosis than in patients with OCD, if the cor-
relation in patients is confounded by tics, depression, or
treatment effects.[45,60]
The ERN in our study was as large in the pediatric
unaffected siblings of OCD probands as the pediatric
OCD patients themselves. Our data parallel those de-
scribed in a study of unaffected adult first-degree rela-
tives of OCD probands that consisted mainly of parents
of those probands.[39] However, the effect sizes in our
study for pediatric OCD patients and unaffected siblings
at Cz (Cohen’s d = .56 and .57, respectively) are smaller
than those in the previous adult study for patients and
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Figure 1. Grand averages of EEG recordings in OCD patients, unaffected siblings, and healthy comparison subjects.a Note: aThe
images depict response-locked grand average waveforms recorded at electrode Cz for correct and incorrect responses. Responses
occurred at 0 ms. The mean amplitude of the ERN was computed in a window from 0 to 80 ms following the incorrect response. OCD,
obsessive-compulsive disorder.
unaffected first-degree relatives at FCz (Cohen’s d = .82
and .79, respectively), suggesting the ERN differences
may be more robust in adults. Our preliminary results
require replication with a larger sample of unaffected
siblings of pediatric OCD probands with a wider age
range.
The ERN has been proposed as an endophenotype
for OCD because it is heritable, reliable, continuously
variable in the general population, associated with at
least a form of the illness, primarily state-independent,
and increased more often in unaffected case relatives
than in the general population.[18,19,37–39,43,45] However,
it is unknown whether an enlarged ERN tends to co-
segregate with OCD in multiply affected families or lies
on the causal pathway between genes and disorder and
is, thereby, more reflective of the causes than the conse-
quences of the disorder. There are no studies, in particu-
lar, showing association or linkage between theERNand
a consistently replicated candidate gene for OCD. Fur-
ther research is necessary to determinewhether variation
in the ERNmediates the genetic risk for the clinical phe-
notype rather than indicating risk through pleiotropic
effects by sharing a set of genes with the clinical pheno-
type. Even if the ERN is a liability index rather than an
intermediate phenotype, it may still be useful in identify-
ing susceptibility alleles depending on whether it defines
a more genetically homogeneous disease subgroup or
identifies carriers of the risk genotype among unaffected
relatives.[18] An alternative term such a “biomarker”may
be more appropriate in this instance, as well as better
describing the current status of the ERN as a possible
genetic correlate of OCD.[19]
Our study has several limitations requiring further
consideration. The sample size for the unaffected sib-
ling group, in particular, was small. Examination of all
first-degree relatives may have provided a more rigorous
examination of the hypothesis that ERN amplitude is el-
evated in unaffected as well as affected relatives of OCD
probands. No corrections were made for multiple test-
ing, although one-tailed tests may have been justified for
the main comparisons. The treatment of patients in this
study was uncontrolled, with the exception that patients
on medications other than the SSRIs were excluded. Al-
though unaffected siblings and healthy controls had no
history of an axis I disorder or significant differenceswith
CBCL, MASC, or CDI measures, it is possible the two
groups had psychological differences that were not as-
sessed. For example, the unaffected siblings and healthy
controlsmay have differed onmeasures of perfectionism,
excessive concern about errors, negative affect, intoler-
ance of uncertainty, inflated responsibility, or overesti-
mation of threat.[68,69] Assessment of these psychological
factors may be useful in future family and longitudinal
studies of the ERN in OCD.
Our study provides further evidence of increased
error-related brain activity in pediatric OCD patients
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that appears independent of symptom severity, cur-
rent diagnostic status, and treatment effects.[43]
Moreover, our results demonstrate a similar increase
in error-related brain activity in unaffected pediatric
siblings of OCD probands in analyses accounting for
correlated data, which extend the findings from a pre-
vious study with unaffected adult relatives of OCD
probands.[39] Thus, the ERN is a promising biomarker
for OCD that may be a useful quantitative phenotype in
genetic studies of this complex trait.[18,19,70] and predic-
tor of outcome in longitudinal studies.
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